$128.36 0.43 (0.34%)
15:57 EDT ZTS Stock Quote Delayed 15 Minutes
Previous Close $127.93
Market Cap 62.11B
PE Ratio 64.50
Volume (Avg. Vol.) 1.20M
Day's Range 127.93 - 129.02
52-Week Range 78.90 - 130.20
Dividend & Yield 0.38 (0.29%)
ZTS Stock Predictions, Articles, and Zoetis News
- From InvestorPlace
- From the Web
Both bulls and bears are converging on the latest geopolitical news items, wrestling for control of global markets. Given the uncertainties involved, protecting yourself with these safe stocks to buy seems like the most reasonable strategy.
The stock charts of NRG, WFC and ZTS deserve some technical scrutiny on this week's hump-day, as each is getting close to a bigger move.
The stock charts of Zoetis, News Corp and SCANA Corporation deserve a second, trading-oriented look on Wednesday morning.
General Electric being removed from the Dow reminds us that businesses can come and go. Here are seven stocks to buy I’d like to see in the Dow.
Abaxis (ABAX) stock was flying high Wednesday on news that Zoetis (ZTS) is acquiring it for $2.00 billion, or $83 per share.
We present four large cap drug companies, which are expected to repeat their last year’s industry beating performance in 2018. Compare Brokers...
It may be all about taxes now, but 2018 is all about healthcare. The following are some of the best healthcare stocks to buy in 2018.
Nine notable dividend stocks raised their payouts last week, including Realty Income (O) and CVS Health (CVS). Here's what you need to know.
The following stocks were moving the Manufacturing sector today.
Eight notable dividend stocks raised their payouts last week, including Mastercard (MA) and Zoetis (ZTS). Here's what you need to know.
P/E isn't the only way to suss out disasters in the making. Here, free cash flow will lead us to some loser S&P 500 stocks to get rid of.
Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat
The health care sector has led the market decline over the past few days, and this stock's chart is showing signs of severe weakness...
The grades of 4 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!